Adjuvant chemotherapy for resectable gastric cancer: A preliminary report

Fong‐Fu ‐F Chou, Shyr‐Ming ‐M Sheen‐Chen, Po‐Pen ‐P Liu, Feng‐Chi ‐C Chen

研究成果: 雜誌貢獻文章同行評審

26 引文 斯高帕斯(Scopus)


In this prospectively random study, the effect of oral Ftorafur as an adjuvant chemotherapy was compared with that of oral placebo in patients with Stage II and Stage III gastric cancer. Patients had undergone a subtotal gastrectomy with a resection margin that should have been free of tumors. Ftorafur (10 mg/kg) was given daily to 59 Group A patients. Multiple vitamins were given twice a week to 56 Group B patients. We found that there was no statistical significance in Stage II patients with regard to survival. In Stage III patients, those treated with oral Ftorafur had better ‐3‐year and 5‐year survival rates than those receiving oral placebo. This preliminary report on this ongoing study seems to indicate that long‐term postoperative Ftorafur treatment may be beneficial to Stage III gastric cancer patients. © 1994 Wiley‐Liss, Inc.

頁(從 - 到)239-242
期刊Journal of Surgical Oncology
出版狀態已發佈 - 12月 1994

ASJC Scopus subject areas

  • 手術
  • 腫瘤科


深入研究「Adjuvant chemotherapy for resectable gastric cancer: A preliminary report」主題。共同形成了獨特的指紋。